DHC
Diversified Healthcare Trust Real Estate - REIT - Healthcare Facilities Investor Relations →
Diversified Healthcare Trust (DHC) closed at $8.86 as of 2026-06-19, trading 187.8% above its 200-week moving average of $3.08. The stock is currently moving closer to the line, down from 196.8% last week. With a 14-week RSI of 70, DHC is in overbought territory.
Over the past 14 weeks, down-weeks have had more trading volume than up-weeks (0.68 buyers-vs-sellers ratio). That means when people are active, they're more often selling than buying. Sellers are still more in control than buyers.
Over the past 1325 weeks of data, DHC has crossed below its 200-week moving average 11 times. On average, these episodes lasted 37 weeks. Historically, investors who bought DHC at the start of these episodes saw an average one-year return of +44.2%.
With a market cap of $2.1 billion, DHC is a mid-cap stock. The company generates a free cash flow yield of 11.5%, which is notably high. Return on equity stands at -17.9%. The stock trades at 1.3x book value.
Over the past 25.5 years, a hypothetical investment of $100 in DHC would have grown to $399, compared to $861 for the S&P 500. DHC has returned 5.6% annualized vs 8.8% for the index, underperforming the broader market over this period.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: DHC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After DHC Crosses Below the Line?
Across 11 historical episodes, buying DHC when it crossed below its 200-week moving average produced an average return of +43.2% after 12 months (median +17.0%), compared to +13.1% for the S&P 500 over the same periods. 73% of those episodes were profitable after one year. After 24 months, the average return was +40.9% vs +30.0% for the index.
Each line shows $100 invested at the moment DHC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. DHC currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from DHC's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
DHC has crossed below its 200-week MA 11 times with an average 1-year return of +44.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Oct 2002 | Oct 2002 | 1 | 0.4% | +65.8% | +263.2% |
| Oct 2008 | Jun 2009 | 33 | 35.6% | +18.9% | +31.9% |
| Jun 2009 | Jul 2009 | 5 | 10.8% | +37.7% | +33.1% |
| May 2015 | May 2016 | 52 | 27.9% | +2.4% | -26.2% |
| Nov 2016 | Dec 2016 | 6 | 2.1% | +17.1% | -27.1% |
| Jan 2018 | May 2018 | 16 | 9.5% | -11.5% | -30.3% |
| Nov 2018 | Dec 2023 | 265 | 85.1% | -41.8% | -22.9% |
| Mar 2024 | Jun 2024 | 12 | 13.3% | +9.4% | +271.8% |
| Nov 2024 | Nov 2024 | 2 | 4.7% | +86.4% | +257.8% |
| Dec 2024 | Jan 2025 | 7 | 16.3% | +95.0% | +269.5% |
| Mar 2025 | May 2025 | 5 | 12.1% | +207.0% | +293.6% |
| Average | 37 | — | +44.2% | — |
Frequently Asked Questions
Is DHC below its 200-week moving average?
No. Diversified Healthcare Trust (DHC) is currently 187.8% above its 200-week moving average of $3.08. It would need to fall to $3.08 to cross below the line.
What is DHC's 200-week moving average price?
Diversified Healthcare Trust's 200-week moving average is $3.08 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when DHC drops below its 200-week moving average?
DHC has crossed below its 200-week moving average 11 times in our data. On average, buying at that moment produced a one-year return of +44.2%. These dips have historically been decent entry points. These episodes lasted 37 weeks on average.
Is DHC a good value right now?
Here's what our data says about DHC as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 70 (overbought). Free cash flow yield is 11.5%. Return on equity is -17.9%. Price-to-book is 1.3x. This is not a buy or sell recommendation — always do your own research.
How does DHC compare to the S&P 500?
Over the past 25.5 years, $100 invested in DHC would have grown to $399, compared to $861 for the S&P 500. That's 5.6% annualized vs 8.8% for the index. DHC has underperformed the broader market over this period.
Does DHC pay a dividend?
Yes. Diversified Healthcare Trust currently pays a dividend yield of 45.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19